vancomycin has been researched along with fibrinogen in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (14.29) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (28.57) | 29.6817 |
2010's | 3 (42.86) | 24.3611 |
2020's | 1 (14.29) | 2.80 |
Authors | Studies |
---|---|
Coller, BS; Gralnick, HR; Lundberg, WB | 1 |
Ames, B; Bayer, AS; Chai, YL; Le, T; Patti, JM; Prater, B; Robbins, J; Schneider, A; Syribeys, P; Vernachio, J | 1 |
Stief, TW | 1 |
Hartmann, B; Keller, F; Maus, S; Rothermund, L | 1 |
Anderson, JM; Hofmann, CM; Marchant, RE | 1 |
Heiss, C; Hess, U; Hill, S; Rezwan, K; Streckbein, P; Treccani, L | 1 |
Babić, G; Krečak, I; Skelin, M | 1 |
7 other study(ies) available for vancomycin and fibrinogen
Article | Year |
---|---|
Effects of vancomycin on platelets, plasma proteins and hepatitis B surface antigen.
Topics: Animals; Blood Coagulation; Chemical Precipitation; Factor VIII; Fibrinogen; Hepatitis B Antigens; Humans; Platelet Aggregation; Rabbits; Time Factors; Vancomycin | 1975 |
Anti-clumping factor A immunoglobulin reduces the duration of methicillin-resistant Staphylococcus aureus bacteremia in an experimental model of infective endocarditis.
Topics: Animals; Anti-Bacterial Agents; Bacteremia; Endocarditis, Bacterial; Female; Fibrinogen; Flow Cytometry; Humans; Immunoglobulin G; Immunoglobulins; Immunotherapy; Methicillin Resistance; Opsonin Proteins; Rabbits; Recombinant Proteins; Staphylococcal Infections; Vancomycin | 2003 |
The fibrinogen antigenic turbidimetric assay (FIATA): the X2x test--the corrected chi-square comparison against the control-mean.
Topics: Antigens; Chemical Precipitation; Chi-Square Distribution; Fibrinogen; Humans; Nephelometry and Turbidimetry; Photometry; Reference Standards; Vancomycin | 2007 |
Thrombocytopenia, INR prolongation and fall in fibrinogen under daptomycin.
Topics: Anti-Bacterial Agents; Aza Compounds; Daptomycin; Endocarditis, Bacterial; Fibrinogen; Fluoroquinolones; Humans; International Normalized Ratio; Male; Middle Aged; Moxifloxacin; Quinolines; Renal Dialysis; Staphylococcal Infections; Staphylococcus epidermidis; Thrombocytopenia; Vancomycin | 2011 |
Targeted delivery of vancomycin to Staphylococcus epidermidis biofilms using a fibrinogen-derived peptide.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Biofilms; Drug Delivery Systems; Fibrinogen; Humans; Molecular Sequence Data; Peptides; Staphylococcal Infections; Staphylococcus epidermidis; Vancomycin | 2012 |
A mild one-pot process for synthesising hydroxyapatite/biomolecule bone scaffolds for sustained and controlled antibiotic release.
Topics: Agar; Animals; Anti-Bacterial Agents; Biocompatible Materials; Bone and Bones; Bone Substitutes; Cattle; Diffusion; Drug Delivery Systems; Durapatite; Fibrinogen; Gentamicins; Materials Testing; Osteomyelitis; Porosity; Pressure; Serum Albumin; Stress, Mechanical; Tissue Scaffolds; Vancomycin | 2015 |
Scurvy.
Topics: Anemia; Anticoagulants; Ascorbic Acid; Ascorbic Acid Deficiency; C-Reactive Protein; Colistin; Contracture; Fatigue; Fibrinogen; Humans; Linezolid; Male; Middle Aged; Prothrombin; Renal Insufficiency; Scurvy; Serum Albumin; Thromboplastin; Vancomycin; Vitamins | 2022 |